SIKA.SW

A large, established market that Sika leads rather than created. It is the category leader in construction chemicals (admixtures, waterproofing, sealants, roofing, flooring and industrial bonding) in a market management sizes at CHF 100 billion where the top 30 players hold only about 50% of revenue, Sika has roughly 12% share, and is twice the size of its closest peer. Demand has both structural legs (tighter building codes, durability and refurbishment, infrastructure, decarbonization that favors higher-performance formulations) and cyclical legs (housing, rates, commercial starts). But this is share gain and adjacency expansion across a mature, fragmented, deeply cyclical market, not category creation, and 2026 is expected to bring a low-single-digit decline in the global construction market. The ceiling is high in absolute terms yet fragmented across overlapping macro, construction, raw-material and FX cycles, which caps how cleanly it compounds. High but ordinary ceiling.

A five-year double is unlikely. Sales rose from CHF 9.25 billion in 2021 to CHF 11.20 billion in 2025, but 2025 actually fell 4.8% in Swiss francs (only +0.6% in local currency, organic -0.4%), and 2026 guidance is just 1% to 4% local-currency growth with the first half softer than the second. Doubling to roughly CHF 22 billion by 2030 would need sustained low-teens compounding from an CHF 11 billion base in a market expected to shrink in 2026, which neither organic momentum nor realistic bolt-on M&A supports. Growth is volume-, mix- and acquisition-led, not price-led, and the strong franc keeps masking the underlying local trend. A low-single-digit organic compounder lifted modestly by acquisitions, well short of a double.

A second curve exists but sits inside the same domain. Growth is broadening from general construction into refurbishment (about 45% of group sales, 70% in mature markets), data centers, infrastructure, low-carbon and durability-led formulations, plus continued geographic expansion through bolt-on M&A. SikaProof A+, a patented waterproofing system, grew around 27% annually from 2023 to 2025, and the company keeps opening production sites and signing deals such as Akkim. But these are adjacencies within construction and industrial chemistry rather than a genuinely new business engine, and the largest single swing factor remains the construction cycle and China. Real and visible, but an extension of the core rather than a separate growth platform.

A genuinely strong and durable moat on three pillars. First, local formulation and technical service at global scale: 103 national subsidiaries, more than 400 factories, 16 technology centers, about 1,800 R&D specialists and more than 5,500 patents create installed know-how tied to local standards, substrates, weather and contractors that a rival cannot copy as fast as it can copy a formula. Second, specification and switching cost: waterproofing and admixtures are small shares of project cost but large shares of project risk, so once a system is specified and field-proven the incentive to switch for a marginal saving is low. Third, acquisition-integration capability: Sika reviews 60 to 80 targets a year, closes few, and turned MBCC into CHF 182 million of 2025 synergies, making capital allocation itself part of the moat. Over three to five years the moat widens in reach as the group consolidates a fragmented market, though per-unit returns depend on synergy delivery and demand normalization. Best-in-class durability.

Strong adaptive DNA and candid disclosure. From a 1910 waterproofing admixture used in the Gotthard Tunnel, Sika reinvented itself from an admixtures specialist into a global system seller across eight target markets, then into the outright scale leader in construction chemicals through Parex in 2019 and MBCC in 2023. It internationalized through local subsidiaries rather than exporting from one plant, building the local-for-local model that now cushions tariffs and input shocks. On bad news, management has been specific about the 2025 squeeze (China weakness, FX drag, organic -0.4%) and launched the Fast Forward plan, with up to 1,500 job cuts and CHF 108 million of one-offs, rather than hiding the strain. The limit is that reinvention stays within adjacent construction and industrial-chemistry markets. Proven ability to remake itself, bounded by its domain.

Professional long-term stewardship with proven capital allocation, though not founder-led. CEO Thomas Hasler (CEO since 2021, decades at Sika) and CFO Adrian Widmer (CFO since 2014) run a business where deep institutional knowledge of subsidiaries, procurement, formulations and integration is itself an asset, and the 2024 board transition to chair Thierry Vanlancker was orderly. Governance is materially cleaner since the 2018 Saint-Gobain settlement introduced one-share-one-vote and ended the control battle, with a diversified register (BlackRock, UBS, Norges) and no controlling-owner discount. Capital allocation is the strongest evidence: disciplined M&A (60 to 80 targets reviewed a year, few closed), rising MBCC synergies, a maintained A- rating, and steady shareholder returns. The gap versus what Baillie most prizes is the absence of a founder-owner alignment block; this is institutional, professional stewardship rather than owner-operator skin in the game.

Genuinely hard to replace in its core, and constructive. Sika's chemistry sits where failure is far more costly than price (waterproofing a tunnel, admixtures in structural concrete, bonding in industrial assembly), so once specified and field-proven its systems are sticky and slow to displace. The business is socially useful: it improves durability, supports infrastructure and refurbishment, and develops lower-carbon, higher-performance formulations that reduce cement and steel intensity, and it does not depend on harming users. The caveats are that a meaningful slice of demand is cyclical construction exposed to price competition in lower-spec categories, especially in a weak China market, and that two antitrust investigations remain disclosed (though U.K., Turkey and U.S. probes closed in 2025). Indispensable in mission-critical categories, more contestable across the broader cyclical mix.

High-quality cash economics, with returns on capital optically depressed by acquisition accounting. Operating cash flow averaged about 1.31 times net profit over 2021 to 2025, operating free cash flow reached CHF 1.356 billion in 2025 (12.1% of sales), net working capital improved to 18.5% of sales, and 2025 owner earnings of roughly CHF 9.0 per share exceeded diluted EPS of CHF 6.50, a genuine cash-generation marker. Material margin recovered from 49.4% in 2022 to 54.9% in 2025, showing pricing, procurement and formulation strength rather than a one-year fluke. The blemish is reported ROCE, which fell from 20.1% in 2021 to 12.3% in 2025; much of that is the denominator effect from Parex and MBCC goodwill, and pre-deal organic returns were excellent, but the larger capital base still needs synergy delivery and demand recovery to lift returns again. Strong cash quality, returns awaiting normalization.

A ten-year 5x is not realistic on the report's own math. From CHF 168 that needs roughly 17.5% annualized, but the base case projects owner earnings of about CHF 9.0 to 9.6 per share by 2028 on a 19x-20x multiple, implying fair value near CHF 171 to 192, and even the optimistic scenario reaches only about CHF 210 to 238 with a +9% price CAGR. A quintuple would require sustained double-digit growth, full margin recovery, a clean China rebound and durable premium re-rating all at once, against a CHF 27 billion mature cyclical base where 2026 growth is guided at 1% to 4%. Respectable mid-single-digit compounding plus dividends is plausible; a 5x is far beyond what the fundamentals support.

The market understands the quality; this is a fully-priced compromise, not a misunderstood stock. At CHF 168, down about 23.8% over twelve months and near the lower end of a CHF 120.35 to 221.00 range, Sika trades around 24x to 26x trailing earnings (about 18.7x owner earnings), a clear discount to its former scarcity premium but well above broad building-materials peer Saint-Gobain (about 14x) and only modestly above higher-quality overlap names RPM (21.5x) and H.B. Fuller (21.8x). The premium is largely earned and largely recognized. The residual gap is timing: whether China stabilizes, U.S. commercial demand recovers, and the 19.5% to 20.0% 2026 EBITDA-margin target turns into fact fast enough to re-earn a wider premium. Absent that proof, a good business can stay a mediocre near-term stock. Fairly valued, awaiting margin and growth confirmation.